78 related articles for article (PubMed ID: 29163485)
1. A Novel Affinity Tag, ABTAG, and Its Application to the Affinity Screening of Single-Domain Antibodies Selected by Phage Display.
Hussack G; Baral TN; Baardsnes J; van Faassen H; Raphael S; Henry KA; Zhang J; MacKenzie CR
Front Immunol; 2017; 8():1406. PubMed ID: 29163485
[TBL] [Abstract][Full Text] [Related]
2. Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species.
Harmsen MM; Ackerschott B; de Smit H
Front Immunol; 2024; 15():1346328. PubMed ID: 38352869
[TBL] [Abstract][Full Text] [Related]
3. Applications of High-Throughput DNA Sequencing to Single-Domain Antibody Discovery and Engineering.
Lowden MJ; Lei EK; Hussack G; Henry KA
Methods Mol Biol; 2023; 2702():489-540. PubMed ID: 37679637
[TBL] [Abstract][Full Text] [Related]
4. From Llama to Nanobody: A Streamlined Workflow for the Generation of Functionalised VHHs.
Eyssen LE; Ramadurai S; Abdelkarim S; Buckle I; Cornish K; Lin H; Jones AK; Stephens GJ; Owens RJ
Bio Protoc; 2024 Mar; 14(6):e4962. PubMed ID: 38841291
[TBL] [Abstract][Full Text] [Related]
5. In Silico-Ex Vitro Iteration Strategy for Affinity Maturation of Anti-Ricin Peptides and the SPR Biosensing Application.
Yang Z; Wang C; Liu J; Xiao L; Guo L; Xie J
Toxins (Basel); 2023 Aug; 15(8):. PubMed ID: 37624247
[TBL] [Abstract][Full Text] [Related]
6. A library approach for the
Arras P; Yoo HB; Pekar L; Schröter C; Clarke T; Krah S; Klewinghaus D; Siegmund V; Evers A; Zielonka S
MAbs; 2023; 15(1):2261149. PubMed ID: 37766540
[TBL] [Abstract][Full Text] [Related]
7. Deep Mining of Complex Antibody Phage Pools Generated by Cell Panning Enables Discovery of Rare Antibodies Binding New Targets and Epitopes.
Ljungars A; Svensson C; Carlsson A; Birgersson E; Tornberg UC; Frendéus B; Ohlin M; Mattsson M
Front Pharmacol; 2019; 10():847. PubMed ID: 31417405
[TBL] [Abstract][Full Text] [Related]
8. Determining the affinities of high-affinity antibodies using KinExA and surface plasmon resonance.
Erasmus MF; Dovner M; Ferrara F; D'Angelo S; Teixeira AA; Leal-Lopes C; Spector L; Hopkins E; Bradbury ARM
MAbs; 2023; 15(1):2291209. PubMed ID: 38088807
[TBL] [Abstract][Full Text] [Related]
9. Alpaca single B cell interrogation and heavy-chain-only antibody discovery on an optofluidic platform.
Shapiro MB; Boucher J; Brousseau A; Dehkharghani A; Gabriel J; Kamat V; Patil K; Gao F; Walker J; Kelly R; Souders CA
Antib Ther; 2023 Jul; 6(3):211-223. PubMed ID: 37680350
[No Abstract] [Full Text] [Related]
10. AI/ML combined with next-generation sequencing of VHH immune repertoires enables the rapid identification of
Arras P; Yoo HB; Pekar L; Clarke T; Friedrich L; Schröter C; Schanz J; Tonillo J; Siegmund V; Doerner A; Krah S; Guarnera E; Zielonka S; Evers A
Front Mol Biosci; 2023; 10():1249247. PubMed ID: 37842638
[No Abstract] [Full Text] [Related]
11. Biosensing-based quality control monitoring of the higher-order structures of therapeutic antibody domains.
Watanabe H; Hayashida N; Sato M; Honda S
Anal Chim Acta; 2024 May; 1303():342439. PubMed ID: 38609254
[TBL] [Abstract][Full Text] [Related]
12. Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy.
Hu Y; Liu C; Muyldermans S
Front Immunol; 2017; 8():1442. PubMed ID: 29163515
[TBL] [Abstract][Full Text] [Related]
13. Camelid Single-Domain Antibodies: Historical Perspective and Future Outlook.
Arbabi-Ghahroudi M
Front Immunol; 2017; 8():1589. PubMed ID: 29209322
[TBL] [Abstract][Full Text] [Related]
14. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
Bannas P; Hambach J; Koch-Nolte F
Front Immunol; 2017; 8():1603. PubMed ID: 29213270
[TBL] [Abstract][Full Text] [Related]
15. Ablynx's nanobody fragments go places antibodies cannot.
Sheridan C
Nat Biotechnol; 2017 Dec; 35(12):1115-1117. PubMed ID: 29220018
[No Abstract] [Full Text] [Related]
16. Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system.
Thom G; Hatcher J; Hearn A; Paterson J; Rodrigo N; Beljean A; Gurrell I; Webster C
MAbs; 2018; 10(2):304-314. PubMed ID: 29182455
[TBL] [Abstract][Full Text] [Related]
17. Yeast surface display platform for rapid discovery of conformationally selective nanobodies.
McMahon C; Baier AS; Pascolutti R; Wegrecki M; Zheng S; Ong JX; Erlandson SC; Hilger D; Rasmussen SGF; Ring AM; Manglik A; Kruse AC
Nat Struct Mol Biol; 2018 Mar; 25(3):289-296. PubMed ID: 29434346
[TBL] [Abstract][Full Text] [Related]
18. Screening and antitumor effect of an anti‑CTLA‑4 nanobody.
Wan R; Liu A; Hou X; Lai Z; Li J; Yang N; Tan J; Mo F; Hu Z; Yang X; Zhao Y; Lu X
Oncol Rep; 2018 Feb; 39(2):511-518. PubMed ID: 29207143
[TBL] [Abstract][Full Text] [Related]
19. Isolation of phage-display library-derived scFv antibody specific to Listeria monocytogenes by a novel immobilized method.
Nguyen XH; Trinh TL; Vu TB; Le QH; To KA
J Appl Microbiol; 2018 Feb; 124(2):591-597. PubMed ID: 29165857
[TBL] [Abstract][Full Text] [Related]
20. Expression of single-domain antibody in different systems.
Liu Y; Huang H
Appl Microbiol Biotechnol; 2018 Jan; 102(2):539-551. PubMed ID: 29177623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
